Here are five points:
1. The Mizuho analysts set a price target of $95 on Amsurg’s stock.
2. Mizuho predicts a potential upside of 20.4 percent from Amsurg’s opening price of $78.88.
3. With a 50-day moving average of $78.60, Amsurg has a 200-day moving average of $77.36.
4. Amsurg stock’s 52-week high is $87.42 and its 52-week low is $54.11.
5. In the past 90 trading days, Amsurg’s share price increased 9.41 points.
More articles on transactions & valuation:
Compass sells Bay Area Physicians Surgery Center following successful turnaround: 5 things to know
Surgery Partners acquires Riverside Pain Physicians; Cantor Fitzgerald analyst claims AmSurg’s latest merger leaves its ASC business’ future hanging in the balance & more — 6 key notes on ASC companies
4 points on Syracuse Orthopedic Specialists meeting patient demand through its orthopedic-driven ASC
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.